- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04005885
A Clinical Comparison of Two Daily Disposable Soft Contact Lenses
December 10, 2020 updated by: Coopervision, Inc.
This double-masked, randomized, bilateral, crossover, direct refit study compared the clinical performance of two daily disposable contact lenses (somofilcon A and stenfilcon A) when fitted to existing wearers of comfilcon A monthly lenses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This double-masked (subject and investigator), randomized, bilateral, crossover, direct refit study compared the clinical performance of two daily disposable test contact lenses (somofilcon A and stenfilcon A) when fitted to existing wearers of comfilcon A monthly lenses.
After a month of re-useable lens wear in the comfilcon A lenses, subjects were randomized to wear each daily disposable lens type for one week.
Study Type
Interventional
Enrollment (Actual)
55
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Manchester, United Kingdom, M13 9PL
- Eurolens Research - The University of Manchester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects will only be eligible for the study if:
- They are between 18 and 40 years of age (inclusive).
- They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
- They are willing and able to follow the protocol.
- They are an existing soft reusable spherical contact lens wearer in both eyes.
- They have a contact lens spherical prescription between -0.50 to -6.00D (inclusive) based on the ocular refraction.
- They have a cylindrical correction of -0.875DC or less in each eye based on the ocular refraction
- They own a wearable pair of spectacles and wear them on the day of the initial visit.
- They have distance high contrast logMAR visual acuity of 0.2 or better in each eye with their habitual spectacles.
- They agree not to participate in other clinical research for the duration of the study.
Exclusion Criteria:
- They have an ocular disorder which would normally contra-indicate contact lens wear.
- They have a systemic disorder which would normally contra-indicate contact lens wear.
- They are using any topical medication such as eye drops or ointment.
- They are aphakic.
- They have had corneal refractive surgery.
- They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
- They are pregnant or breastfeeding.
- They have any infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reaction.
- They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: somofilcon A then stenfilcon A contact lens
Participants were fitted with comfilcon A lens on a daily wear, reusable basis for 1 month, then randomized to wear somofilcon A daily disposable test lens for 1 week of daily wear and stenfilcon A daily disposable test lens for 1 week of daily wear.
|
Contact Lens
Other Names:
daily disposable contact lens
Other Names:
daily disposable contact lens
Other Names:
|
Experimental: stenfilcon A then somofilcon A contact lens
Participants were fitted with comfilcon A lens on a daily wear, reusable basis for 1 month, then randomized to wear stenfilcon A daily disposable test lens for 1 week of daily wear and somofilcon A daily disposable test lens for 1 week of daily wear.
|
Contact Lens
Other Names:
daily disposable contact lens
Other Names:
daily disposable contact lens
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subjective Scores of Comfort at Insertion After 4 Weeks of Comfilcon A Use
Time Frame: 4 weeks
|
Subjective Scores of comfort at Insertion after 4 weeks of Comfilcon A use rated on a scale 0-100 (0=causes pain, cannot be tolerated, 100=excellent, cannot be felt).
|
4 weeks
|
Subjective Scores of Comfort on Insertion
Time Frame: 1 week
|
Subjective Scores of Comfort on Insertion rated on a scale 0 -100 (0=causes pain, cannot be tolerated, 100=excellent, cannot be felt).
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subjective Scores on Overall Comfort After 4 Weeks of Comfilcon Use
Time Frame: 4 weeks
|
Subjective scores on overall comfort after 4 weeks of comfilcon use rated on a scale 0 -100 (0=causes pain, cannot be tolerated, 100=excellent, cannot be felt).
|
4 weeks
|
Subjective Scores on Overall Comfort
Time Frame: 1 week
|
Subjective Scores on overall comfort rated on a scale 0 - 100 (0=causes pain, cannot be tolerated, 100=excellent, cannot be felt).
|
1 week
|
Subjective Scores on Comfort Before Removal After 4 Weeks of Comfilcon Use
Time Frame: 4 weeks
|
Subjective Scores on Comfort before removal after 4 weeks of comfilcon use rated on a scale 0-100 (0=causes pain, cannot be tolerated, 100=excellent, cannot be felt).
|
4 weeks
|
Subjective Scores on Comfort Before Removal
Time Frame: 1 week
|
Subjective Scores on Comfort before removal rated on a scale 0-100 (0=causes pain, cannot be tolerated, 100=excellent, cannot be felt).
|
1 week
|
Number of Participants With Horizontal Lens Centration Grade
Time Frame: Baseline (after 5 minutes of lens dispense)
|
Number of Participants with Horizontal Lens centration graded on scale of -2 to 2 ( -2= Extremely nasal, -1 slightly nasal, 0=optimum, 1=slightly temporal, 2=extremely temporal)
|
Baseline (after 5 minutes of lens dispense)
|
Number of Participants With Horizontal Lens Centration Grade After 4 Weeks of Comfilcon A Wear
Time Frame: 4 weeks
|
Number of Participants with Horizontal lens centration after 4 weeks of comfilcon A wear graded on scale of -2 to 2 ( -2= Extremely nasal, -1 slightly nasal, 0=optimum, 1=slightly temporal, 2=extremely temporal)
|
4 weeks
|
Number of Participants With Horizontal Lens Centration Grade
Time Frame: 1 week
|
Number of Participants with Horizontal Lens centration graded on scale of -2 to 2 ( -2= Extremely nasal, -1 slightly nasal, 0=optimum, 1=slightly temporal, 2=extremely temporal)
|
1 week
|
Number of Participants With Vertical Lens Centration Grade
Time Frame: Baseline (After 5 minutes of lens dispense)
|
Number of Participants with Vertical lens centration graded on a scale of -2 to 2 ( -2= Extremely inferior, -1 slightly inferior, 0=optimum, 1=slightly superior, 2=extremely superior)
|
Baseline (After 5 minutes of lens dispense)
|
Number of Participants With Vertical Lens Centration Grade After 4 Weeks of Comfilcon A Wear
Time Frame: 4 weeks
|
Number of Participants with Vertical lens centration after 4 weeks of comfilcon A wear graded on a scale of -2 to 2 ( -2= Extremely inferior, -1 slightly inferior, 0=optimum, 1=slightly superior, 2=extremely superior)
|
4 weeks
|
Number of Participants With Vertical Lens Centration Grade
Time Frame: 1 week
|
Number of Participants with Vertical lens centration graded on a scale of -2 to 2 ( -2= Extremely inferior, -1 slightly inferior, 0=optimum, 1=slightly superior, 2=extremely superior)
|
1 week
|
Number of Participants With Lens Corneal Coverage Grade
Time Frame: Baseline (after 5 minutes of lens dispense)
|
Number of Participants with Lens Corneal coverage graded on a scale -2 to 2 ( -2=extremely inadequate, -1=slightly inadequate, but acceptable, 0=optimum, 1=slightly excessive, but acceptable, 2=extremely excessive)
|
Baseline (after 5 minutes of lens dispense)
|
Number of Participants With Lens Corneal Coverage Grade After 4 Weeks of Comfilcon A Wear
Time Frame: 4 weeks
|
Number of Participants with Lens Corneal coverage after 4 weeks of comfilcon A wear graded on a scale -2 to 2 ( -2=extremely inadequate, -1=slightly inadequate, but acceptable, 0=optimum, 1=slightly excessive, but acceptable, 2=extremely excessive)
|
4 weeks
|
Number of Participants With Lens Corneal Coverage Grade
Time Frame: 1 week
|
Number of Participants with Lens Corneal coverage graded on a scale -2 to 2 ( -2=extremely inadequate, -1=slightly inadequate, but acceptable, 0=optimum, 1=slightly excessive, but acceptable, 2=extremely excessive)
|
1 week
|
Number of Participants With Post-Blink Movement Grade
Time Frame: Baseline (after 5 minutes of lens dispense)
|
Number of Participants with Post-blink movement graded on a scale of -2 to 2 ( -2=extremely inadequate, -1=slightly inadequate, but acceptable, 0=optimum, 1=slightly excessive, but acceptable, 2=extremely excessive)
|
Baseline (after 5 minutes of lens dispense)
|
Number of Participants With Post-Blink Movement Grade After 4 Weeks of Comfilcon A Wear
Time Frame: 4 weeks
|
Number of Participants with Post-blink movement after 4 weeks of comfilcon A wear graded on a scale of -2 to 2 ( -2=extremely inadequate, -1=slightly inadequate, but acceptable, 0=optimum, 1=slightly excessive, but acceptable, 2=extremely excessive)
|
4 weeks
|
Number of Participants With Post-Blink Movement Grade
Time Frame: 1 week
|
Number of Participants with Post-blink movement graded on a scale of -2 to 2 ( -2=extremely inadequate, -1=slightly inadequate, but acceptable, 0=optimum, 1=slightly excessive, but acceptable, 2=extremely excessive)
|
1 week
|
Investigator Lens Fit Acceptance
Time Frame: Baseline (after 5 minutes of lens dispense)
|
Lens fit acceptance investigator rating for acceptable and optimum fits on 1-5 Likert Scale (1=strongly agree, 2- Agree.
3- Neither agree not disagree, 4- Disagree, 5=strongly disagree)
|
Baseline (after 5 minutes of lens dispense)
|
Investigator Lens Fit Acceptance for Comfilcon A After 4 Weeks of Use
Time Frame: 4 weeks
|
Lens fit acceptance investigator rating for comfilcon A after 4 weeks of use for acceptable and optimum fits on 1-5 Likert Scale (1=strongly agree, 2- Agree.
3- Neither agree not disagree, 4- Disagree, 5=strongly disagree)
|
4 weeks
|
Investigator Lens Fit Acceptance
Time Frame: 1 week
|
Lens fit acceptance investigator rating for acceptable and optimum fits on 1-5 Likert Scale (1=strongly agree, 2- Agree.
3- Neither agree not disagree, 4- Disagree, 5=strongly disagree)
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Carole Maldonado-Codina, PhD, MCOptom, FAAO, FBCLA, Eurolens Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2019
Primary Completion (Actual)
November 8, 2019
Study Completion (Actual)
November 30, 2019
Study Registration Dates
First Submitted
July 1, 2019
First Submitted That Met QC Criteria
July 1, 2019
First Posted (Actual)
July 2, 2019
Study Record Updates
Last Update Posted (Actual)
January 5, 2021
Last Update Submitted That Met QC Criteria
December 10, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EX-MKTG-100
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
He Eye HospitalNot yet recruiting
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting
-
Visioneering Technologies, IncRecruitingMyopiaUnited States, Canada, Hong Kong, Singapore
-
University Eye Hospital, FreiburgRecruiting
-
Shanghai 10th People's HospitalCompletedMyopia | Myopia, ProgressiveChina
-
Tianjin Eye HospitalActive, not recruiting
-
Tianjin Eye HospitalCompleted
-
Sultan Qaboos UniversityChristian Medical College, Vellore, IndiaUnknown
-
Peking University People's HospitalUnknownProgressive MyopiaChina
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
Clinical Trials on comfilcon A
-
Coopervision, Inc.CompletedPresbyopiaUnited States
-
Coopervision, Inc.CompletedPresbyopiaUnited States
-
Coopervision, Inc.Completed
-
Coopervision, Inc.CompletedAstigmatism | MyopiaUnited States
-
Johnson & Johnson Vision Care, Inc.Visioncare Research Ltd.; Foresight Regulatory Strategies, Inc.CompletedRefractive Error
-
Coopervision, Inc.CompletedMyopiaUnited States, United Kingdom